Last reviewed · How we verify
AT04
AT04 is an investigational drug with unknown mechanism of action.
At a glance
| Generic name | AT04 |
|---|---|
| Also known as | Saline |
| Sponsor | Dhp Korea Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 2 |
Mechanism of action
Due to the lack of available information, the exact mechanism of action of AT04 is currently unknown.
Approved indications
Common side effects
Key clinical trials
- Sleep Loss and Circadian Misalignment - Mechanisms of Insulin Resistance (PHASE4)
- The Impact of Treadmills and Cooler Environments for Office Workplaces on Ergonomics, Heating Energy Requirements, Performance, as Well as Back and Cardiometabolic Health (NA)
- Efficacy and Safety Study of ATs in Patients With Dry Eye Syndrome (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |